Seongnam-si, South Korea

Seahyung Lee


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seahyung Lee: Innovator in Antibody Development

Introduction

Seahyung Lee is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. His work focuses on enhancing diagnostic accuracy and therapeutic efficacy related to specific proteins.

Latest Patents

Seahyung Lee holds a patent for "Anti-human ninjurin-1 (NINJ-1) antibodies and methods for detecting human NINJ-1." This invention provides an antibody that specifically binds to human NINJ-1, demonstrating high bonding affinity and specificity. The antibody does not exhibit cross-reactivity with NINJ-1 proteins from other organisms, which is crucial for accurate disease diagnosis. The invention offers significant advantages in diagnosing diseases related to NINJ-1 proteins and inhibiting pathological conditions involving these proteins. Notably, the antibody has shown remarkable effects in treating multiple sclerosis by inhibiting the attachment between immunocytes and human cerebral endothelial cells.

Career Highlights

Throughout his career, Seahyung Lee has worked with prominent organizations, including Abion Inc. and Seoul National University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Young Kee Shin and Kyoung Song. Their collaborative efforts have further advanced the research and development of innovative solutions in biotechnology.

Conclusion

Seahyung Lee's contributions to the field of antibody development highlight his role as an influential inventor. His patented work not only enhances diagnostic capabilities but also offers potential therapeutic benefits for conditions like multiple sclerosis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…